SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report: (Date of earliest event reported) : ~~December~~March 312, ~~2011~~2012

Commission File No. 333-136643

ONE BIO, CORP.

(Exact name of registrant as specified in its charter)

Florida		59-3656663
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)
(State or other jurisdiction of		(IRS Employer Identification No.)
incorporation or organization)

19950 West Country Club Drive, Suite 100, Aventura, FL 33180

(Address of principal executive offices)

305-328-8662

--------------------------------------

(Issuer telephone number)

(Former Name and Address)

~~Item~~Check ~~2.01 Completion~~the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of ~~Acquisition~~the orregistrant ~~Disposition~~under any of ~~Assets.~~the following provisions:

~~As previously reported in the current report on Form 8-K filed by ONE Bio, Corp. (“Company” or “ONE”) with the SEC on September 9, 2009, on September 3, 2009,~~o ~~the~~Written ~~Company~~communications ~~acquired 3,990 shares of common stock (the "TFS Shares"), of Trade Finance Solutions Inc., an Ontario corporation (“TFS”),~~ pursuant to ~~that~~Rule ~~certain~~425 ~~Share~~under ~~Purchase Agreement (~~the ~~“Share~~Securities ~~Purchase~~Act ~~Agreement”) by and among the Company, TFS and the stockholders of TFS~~ (~~the “Stockholders”) for a total consideration of $1,279,914 (the “Cash Purchase Price”) and~~ 17~~,066~~ ~~shares~~CFR ~~of common stock of the Company (the “Equity Consideration”)~~230.425)

~~Effective~~o Soliciting ~~December~~material ~~31, 2011, the Company entered into and consummated transactions~~ pursuant to anRule ~~Assignment~~14a-12 ~~Agreement~~under ~~substantially in~~ the ~~form~~Exchange ofAct ~~Exhibit 10.1 annexed hereto~~ (~~the~~17 ~~“Assignment~~CFR ~~Agreement”) whereby the Company assigned to Global Fund Holdings, Corp~~240.~~, an Ontario corporation (the “Assignee”~~14a-12), the TFS Shares and the Share Purchase Agreement and all of the obligations thereunder, including, but not limited to, the Company’s obligation to pay the Cash Purchase Price and Equity Consideration (the “Assignment”). In consideration of the Assignment, the Assignee assumed and agreed to perform all covenants, agreements, and undertakings of the Company which either have not yet been performed by the Company or those arising under the Share Purchase Agreement after the date of the Assignment.

~~Effective~~o Pre-commencement ~~December~~communications ~~31,~~pursuant ~~2011,~~to ~~the~~Rule ~~Company also entered into a Waiver and Consent agreement with the Stockholders substantially in the form of Exhibit 10.~~14d-2(b) ~~annexed~~under ~~hereto, whereby~~ the ~~Stockholders~~Exchange ~~have~~Act ~~consented~~(17 toCFR ~~the Assignment~~240.14d-2(b))

~~Item 9.01~~o ~~Financial~~Pre-commencement ~~Statements~~communications ~~and~~pursuant ~~Exhibits~~to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

ITEM 2.01 COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.

As previously reported in the current report on Form 8-K filed by ONE Bio, Corp. (“Company” or “ONE”) with the SEC on April 20, 2010, on April 14, 2010, the Company acquired from Min Zhao (the “Selling Shareholder”) among other things, 1,632,150 shares of common stock of Green Planet Bioengineering Co. Limited, a Florida corporation (“Green Planet”), owned by the Selling Shareholder in consideration for 260,000 shares (adjusted for the 1 for 5 stock splits of August 2010) of the Company’s restricted common stock pursuant to a Share Purchase Agreement. At the same time, the Company received from a certain Green Planet shareholder 1,216,184 shares of common stock of Green Planet. As a consequence of these transactions, the Company acquired and controlled 18,508,733 shares of the common stock of Green Planet, representing 92.5% of the outstanding common stock of Green Planet.

Effective March 2, 2012, the Company entered into and consummated transactions pursuant to a Stock Purchase Agreement substantially in the form of Exhibit 10.1 annexed hereto (the “SPA”) whereby the Company sold the 18,508,733 shares of the common stock of Green Planet to Global Fund Holdings, Corp., an Ontario corporation (the “Purchaser”) for a total consideration of $200,000 (the “Purchase Price”). The Purchase Price will be paid to the Purchaser by setting off the same amount of the liabilities that the Company owed to Trade Finance Solutions, Inc., a wholly owned subsidiary of the Purchaser as of the date of the SPA.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d) The following exhibits are filed with this report:

Exhibit No. Description

Exhibit No.		Description

10.1		Stock Purchase Agreement dated as of March 2, 2011, by and between One Bio, Corp. and Global Fund Holdings, Corp.

~~10.1 Assignment Agreement dated as of December 31, 2011, by and among ONE Bio, Corp., Global Fund Holdings, Corp. and Trade Finance Solutions Inc.~~2

10.2 Waiver and Consent Agreement dated as of December 31, 2011, by and among ONE Bio, Corp., Melanie Kerekes, Jim Oattes, Tomas Anleo Gonzales, Vern Ralphs, Steve McDonald, Peter Cook, and Michael Weingarten.

Signatures

Pursuant to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ONE Bio, Corp.
January 27, 2012	By:	/s/ Marius Silvasan
March 26, 2012	By:	/s/ Marius Silvasan
		Marius Silvasan
		Chief Executive Officer and Director
January 27, 2012	By:	/s/ Cris Neely
March 26, 2012	By:	/s/ Cris Neely
		Cris Neely
		Chief Financial Officer and Director

Filing Compare · ONE Bio, Corp.